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RESUMO
O estudo teve como objetivos caracterizar e
identificar a comorbidade entre fadiga e de-
pressão em pacientes com câncer colorretal.
A amostra não-probabilística foi de 154 paci-
entes ambulatoriais (53% homens; idade
média 49,6±11,7 anos; escolaridade média
8,9±5,4 anos). A fadiga foi avaliada pela Esca-
la de Fadiga de Piper Revisada e o humor pelo
Inventário de Depressão de Beck. A Fadiga foi
relatada por 76 (49,4%) pacientes e foi inten-
sa (escore total > 6) para 19,7% deles. Esco-
res que sugerem depressão (IDB>20) foram
encontrados em 11 (7,1%) pacientes. Fadiga e
depressão estavam correlacionadas (r=0,395;
p 0,001). A co-morbidade fadiga moderada/
intensa e disforia/depressão ocorreu em
12,3%. A Fadiga estava presente na totalida-
de dos doentes deprimidos (100%), e a de-
pressão ocorreu em 18% dos doentes fatiga-
dos. Fadiga e depressão são fenômenos rela-
cionados, a sua comorbidade pode ser muito
deletéria ao doente; a depressão foi mais im-
portante para a ocorrência de fadiga do que
a fadiga para a depressão.
DESCRITORES
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ABSTRACT
The objective of this study was to identify and
characterize the comorbidities of fatigue and
depression in colorectal cancer patients. A
non-probabilistic sample of 154 outpatients
(53% men; mean age 49.6±11.7 years; mean
education 8.9±5.4 years). Fatigue was evalu-
ated using the Revised Piper Fatigue Scale
(min:0; max:10) and depression was evalu-
ated using the Beck Depression Inventory
(BDI) (min:0; max: 63). Fatigue was identified
by 76 (49.4%) patients, and was intense (to-
tal score > 6) for 19.7% . Scores compatible
with depression (BDI> 20) were found in 11
(7.1%) patients. Fatigue and depression were
correlated (r= 0.395, p<0.001). Comorbidities
of moderate/severe fatigue and dysphoria/
depression occurred in 12.3%. Fatigue was
present in all patients with depression (100%)
and depression occurred in 18% of patients
with fatigue. Fatigue and depression are re-
lated phenomena.  Comorbidities can be del-
eterious to the patient. Depression had a
stronger effect on the occurrence of fatigue
than the effect of fatigue on depression.
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RESUMEN
El estudio tuvo como objetivos caracterizar e
identificar la relación entre la fatiga y la de-
presión en pacientes con cáncer colon-rectal.
La muestra no probabilística fue de 154 pa-
cientes de ambulatorio (53% hombres; edad
promedio 49,6±11,7 años; escolaridad pro-
medio 8,9±5,4 anos). La fatiga fue evaluada
por la Escala de Fatiga de Piper Revisada y el
humor por el Inventario de Depresión de
Beck. La Fatiga fue relatada por 76 (49,4%)
pacientes y fue intensa (puntaje total > 6) para
19,7% de ellos. Puntajes que sugieren depre-
sión (IDB>20) fueron encontrados en 11
(7,1%) pacientes. La fatiga y la depresión es-
taban correlacionados (r= 0,395; p 0,001). La
enfermedad concomitante fatiga moderada/
intensa y disforia/depresión ocurrió en 12,3%.
La Fatiga estaba presente en la totalidad de
los enfermos deprimidos (100%), y la depre-
sión ocurrió en 18% de los enfermos fatiga-
dos. Fatiga y depresión son fenómenos rela-
cionados (concomitantes), y su acción puede
ser muy deletérea para el enfermo; la depre-
sión fue más importante para la ocurrencia
de fatiga que la fatiga para la depresión.
DESCRIPTORES
Neoplasias colorrectales.
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Depresión.
Atención paliativa.
905Rev Esc Enferm USP2009; 43(4):904-9www.ee.usp.br/reeusp/
Comorbidities between fatigue and
depression in patients with colorectal cancer
Santos J, Mota DDCF, Pimenta CAM
INTRODUCTION
Fatigue and depression are mentioned in international
literature as common symptoms in patients with cancer.
However, the relationship between them is insufficiently
understood, especially in colorectal cancer cases. In Brazil,
fatigue and depression occurrence and prevalence in can-
cer patients are not well known. The evaluation and record
of these symptoms are not appropriately taken according
to what is inferred by a study on the record of subjective
symptoms in this sector(1).
Fatigue occurs in 19 to 99% of patients and its frequency
and magnitude vary as the evolution of the oncologic dis-
ease(2-4). It regards an unpleasant feeling with physical, psychic
and emotional symptoms described as a type of tiredness that
is not improved by the usual energy recovery strategies(5). It
varies in intensity and duration and reduces, in different grades,
the ability of performing daily tasks(5). It is multifactor, impact-
ing various life domains; also, the factors composing it are not
yet well-known. Among emotional factors, depression is most
studied. It occurs between 1.5 to 57% of cancer patients(6-7)
and can affect patients at any phase of the disease(6-7).
Fatigue follows humor disorders. Depres-
sion is considered a triggering factor for fa-
tigue(8), but the magnitude of this correlation
is still not certain. It is described as varying
around 0.16 to 0.8(9).
Depression is a humor affection disorder
characterized by global organic and psychic
alterations, for a minimum period of two
weeks, involving depression episodes and at
least four of the following symptoms: sadness
complaints, hopelessness, loss of general pleasure, loss of
appetite, sleep disturbances, psychomotor alterations, en-
ergy decrease, feelings of uselessness and guilt, and sui-
cidal thoughts(10). Depression prevalence in colorectal can-
cer patients occurs in 36.7% of patients(11).
Only a few studies have analyzed the relationship be-
tween fatigue and depression in patients with colorectal
cancer(11) and none have identified comorbidities among
the symptoms. These facts have motivated the elaboration
of this present study.
OBJECTIVES
This study has the objective of characterizing and iden-
tifying comorbidities between fatigue and depression in
colorectal cancer patients.
METHOD
Sample, location and period
This is a cross-sectional study, with a non-probabilistic
sample of 154 patients with primary colon or rectal cancer,
undergoing clinic treatment. At any stage of the disease,
age equal or over 18 years old and appropriate capacity to
understand and verbalize attained by six years of minimum
educational level.  Collection was carried out into four on-
cology services of the city of São Paulo (Cancer Hospital
A.C. Camargo, Santa Helena Hospital, Brigadeiro Hospital
and Nove de Julho Oncology Clinics), from July of 2006 to
June of 2007, after the approval from the Research Ethics
Committee of these institutions (Protocol No. 511/2005/
REC-EEUSP). All patients who agreed to participate signed
a two-copy Free and Informed Consent Form.
Procedures and Data Collection Instruments
Data collection team was composed by the main re-
searcher, three nurses and one nursing graduation student.
Collection procedures were standardized and all parties
were previously trained with the aim to ensure data impar-
tiality and fidelity.
Patients were forwarded by the oncology services to
collectors. After certifying inclusion criteria and they agreed
to participate in the research, collectors interviewed the
subjects. After signing the Free and Informed Consent Form,
they were categorized according to socio-demographic
data, from the disease to treatment, func-
tional capacity (Karnofsky’s Scale), fatigue (re-
viewed Piper’s Fatigue Scale) and humor
(Beck’s Depression Inventory – BDI).
Karnofsky’s Scale aimed at measuring the
functional capacity. In other words, it measures
the capability to perform daily life activities.
This was an independent variable of this study.
In the oncology context, this type of measure
is broadly used to determine if the patient can
undergo chemotherapy and if there is a need to adjust the
dose, for instance. The score varies from 100%, which indi-
cates full health, to 0%, which indicates death. Despite its
broad use, there is no acknowledgment of a study where its
psychometric properties were tested in Brazilian culture(12).
The Reviewed Piper’s Fatigue Scale is a multi-dimen-
sional self-report instrument, validated for the Brazilian
culture(13). The Brazilian version was validated with 584 pa-
tients with various cancer types and 373 healthy individu-
als (184 companions and 189 nursing graduation students).
Reliability of this instrument to the sample of this study
was very high (Cronbach á=0.94) and dimensions were con-
firmed by factor analysis.  The instrument has 22 items and
3 dimensions (behavioral/intensity - 6 items, affective - 5
items and sensitive/cognitive and emotional - 11 items).
Total and dimensional score vary from 0 to 10. Cutting points
were established according to score distribution in percent-
age of the sample. Twenty-five percent referred to 3, fifty
percent referred to 4.8 and 75% referred to 6.2. Score 0
represented no fatigue, scores less than 3 indicated light
fatigue, scores equal to 3 and lower than 6 indicated mild
fatigue, and scores equal to or higher than 6, indicated in-
tense fatigue.
Fatigue follows
humor disorders.
Depression is
considered a
triggering factor
for fatigue.
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The Beck’s Depression Inventory was validated for the
Brazilian culture(14). It is composed of 21 items graduated
from 0 to 3; minimum score is 0 (no depression) and maxi-
mum score is 63 (maximum depression). Cutting points
adopted for populations with no previous depression diag-
nosis are: scores between 0 and 15 define absence of de-
pression, scores between 16 and 20 show dysphoria and
scores higher than 20 are compatible to depression. The
reliability tested in this present study was good (Cronbach
α=0.83).
Data analysis
Data were organized into Excel® spreadsheets and sta-
tistics tests were carried out using SPSSv.15.0 software. Co-
morbidities were identified under absolute and relative fre-
quency. The correlation between fatigue and depression
scores was evaluated by the Spearman correlation coeffi-
cient.  Although studies show the relationship between fa-
tigue and/or depression and the characterization variables
of the samples used in this study (socio-demographic, dis-
ease and treatment), they were not evaluated since they
went beyond this study’s objectives.
RESULTS
In Table 1, the sample characteristics are presented.
There was a predominance of colon cancer individuals,
patients with stage IV tumors and of patients undergoing
chemotherapy. Functionality was being maintained in 80%
of patients.
Table 1 - Patients distribution (n=154) according to socio-demographic, disease and treatment characteristics - São Paulo - 2007
N %Socio-Demographic Data
Gender Male 82 53.2
Mean (SD) 59.9 (DP=11.7)Age
Median (Variance) 60 (28-84)
Marital Status Married 104 67.5
Mean (SD) 10.7 (DP=5.4)Education (in years)
Median (Variance) 11 (0-26)
Mean (SD) 1,624.06 (DP=1,811.67)Income per capita (USD$)
U$ 1.00 = R$ 2.00 reais
Median (Variance) 1,062.50 (83-12,000)
Treatment and Disease Data
Colon 108 70.1Primary Tumor Location
Rectal 46 29.9
I 5 3.2
II 17 11.0
III 16 10.4
IV 34 22.1
Stage*
No data 82 53.3
100% - 80% 123 79.9
70% - 60% 25 16.2
Performance Status
(Karnofsky's Scale)
50%
No data
2
4
1.3
2.6
Chemotherapy 94 61.1
Radiotherapy 1 0.6
Chemotherapy +
Radiotherapy
2 1.3
Hormones Therapy 1 0.6
Current treatments
Not under treatment 56 36.4
*Stages were described by the TNM system according to the oncologist’s description in the patient’s medical file
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Table 2 presents the intensity of fatigue and depressive
symptoms. Fifty percent of patients presented fatigue,
where one-fifth of these were intense. Depression was ob-
served in 7% of patients, however, some humor alteration
was reported by 16.2% of the cases.
Table 2 - Presence and intensity of fatigue and depression in colorectal cancer patients - São Paulo - 2007
N %
Fatigue (n=154) Yes 76 49.4
No 78 50.6
Fatigue (n=76)
Light (<3) 15 19.7
Mild ( 3 or <6)< 46 60.5
Mean=4.5 (SD=1.8)
Median=4.4
Variation (1.1 to 9.6) Intense (6 > 10) 15 19.7
Depression (n=154)
Absence of Depression (0-15) 129 83.8
Dysphoria (16 - 20) 1 4 9.1
Mean=9.4 (SD=7.1)
Median=9.0
Variation (0 to 37) Depressive Symptoms (21 - 63) 11 7.1
Table 3 presents fatigue and depression comorbidities.
The correlation between fatigue and depression was posi-
tive, mild and statistically significant (r=0.395; p<0.01).
Around 4.5% of patients presented intense fatigue and de-
pression comorbidities; in 7.1% of the cases, mild/intense
fatigue and depression comorbidities were observed and
in 12.3% of the cases mild/intense fatigue and dysphoria/
depression were observed.
Table 3 - Fatigue and depression in colorectal cancer patients - São Paulo - 2007
Reviewed Piper's Fatigue Scale
No fatigue
(n=78)
Light Fatigue
(n=15)
Mild
Fatigue
(n=46)
Intense
Fatigue
(n=15)
75 12 38 4
3 3 4 4
Beck's
Depression
Inventory
No depression
(n=129)
Dysphoria
(n=14)
Depression
(n=11) 0 0 4 7*
Depression scores X Fatigue scores
Spearman Test r=0.395 p<0.01
* Comorbidities
In patients with depression (n=11), 64% reported intense
fatigue; among patients with intense fatigue (n=15), 46.7%
presented depression. In patients that showed no depres-
sion (n=129), 3.1% presented intense fatigue and in patients
with no fatigue (n=78) none had depression (Table 3).
DISCUSSION
The study demonstrated that fatigue and depression
were positively correlated, occurring in comorbidities and
were frequent among patients. Isolated fatigue and depres-
sion can cause limitations and it can also be even more
deleterious, increase physical, emotional and social inca-
pacity, compromising treatment adherence and causing
considerable suffering to patients and their family.  Few
studies, worldwide, analyzed the relations and comorbidi-
ties between fatigue and depression in colorectal cancer
patients. Nationally, this is the first study.
Approximately half of the sample had experienced some
degree of fatigue (49.4%) and in 39.6% it was mild and in-
tense (Table 2). This prevalence was superior compared to
the one found in colorectal cancer patients and colorectal
cancer survivors (15-16) and inferior to the study that evalu-
ated fatigue in colorectal cancer patients one year after di-
agnosis(17).
Possibly, results discrepancy regards the different
health/sickness conditions and patients’ personal charac-
teristics.  In this present research, the mean age was 60
years old. Most patients had a good educational level and
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preserved functionality. All patients were undergoing clini-
cal treatment. Few studies evaluated the relation between
fatigue and/or depression and socio-demographic variables
as gender, age, educational level, marital status, working
activity, income per capita, and color of skin. They all dem-
onstrated contradictory and inconclusive results.  In addi-
tion to cancer treatments, risk or predicting factors for
symptoms appearance(13) and the disease stage also influ-
ence the prevalence of fatigue and depression. This present
study did not evaluate the relationship between fatigue
and/or depression and the characterizing variables of the
sample.
The reviewed Piper’s Fatigue Scale, used in this study,
demonstrated good reliability. Despite its median exten-
sion (22 items), it did not present fulfilling difficulties.
Among the analyzed results, fatigue was evaluated by vari-
ous instruments Fatigue Severity Scale, Fatigue Question-
naire, the Cancer Fatigue Scale and the Bidimensional Fa-
tigue Scale, European Organization for Research and Treat-
ment of Cancer Quality of Life Questionnaire (EORTC-QLQ
core 30) and the Profile of Mood States Scale (POMS). Dif-
ferent evaluation methods can lead to different results lim-
iting results comparison.
Depression was observed in 7.1% of patients and dys-
phoria in 9.1%. Depression prevalence was slightly supe-
rior to the one found in general Brazilian population (2% to
6%)(13). A similar result to what was observed in studies in-
volving patients with different types of cancer and survi-
vors of Hodgkin’s Lymphoma (8% to 3%)(4) and inferior to
studies on patients under palliative care (35%) and in pa-
tients with colorectal cancer (36.7%)(11). These differences
can be a result from sample differences and different meth-
ods and diagnoses.  The Beck’s Depression Inventory used
in this study was extensively validated in clinical and Brazil-
ian population samples. It demonstrated high reliability for
this sample.  The Hospital Anxiety and Depression Scale
(HADS) was the most used evaluation scale for depression
in the studies analyzed here.
A positive and mild correlation was observes between
fatigue and depression (r=0.395, p=0.001) and no study was
found that analyzed this correlation in patients with
colorectal cancer. Studies involving patients with other types
of cancer found superior correlations that varied between
r=0.55 and r=0.75(3).  Only one study did not find a statisti-
cally significant  correlation between fatigue and depres-
sion (r=0.16)(2). A similar result was found in a study on pa-
tients with Hodgkin’s Lymphoma(4).
Fatigue and depression are related to the worsening of
quality of life and in comorbidities, they can be even more
deleterious.  Comorbidities between fatigue and depres-
sion found in this present study were significant: moder-
ate/intense fatigue and dysphoria/depression comorbidi-
ties were observed in 12.3% of patients, moderate/intense
fatigue and depression comorbidities in 7.1% and intense
fatigue and depression in 4.5% (Table 3). A study involving
52 patients with various types of neoplasm found superior
comorbidities (19.2%) to this present study(18).
Fatigue is a symptom of a depressive condition and also
an item of Beck’s Depression Inventory. Among the 154
patients evaluated in the present study, 64.3% have re-
ported some degree of fatigue. In Piper’s Fatigue Scale,
14.3% of patients reported some degree of depression.
These data suggest fatigue as one of the elements for de-
pression more than depression as one of the elements for
fatigue.  This analysis is also ensured by the findings in the
present study where in patients with depression (n=11),
64% reported intense fatigue, and from intense fatigue
patients (n=15), 46.7% presented depression.
From subjects with moderate/intense fatigue (n=61)18%
presented depression and from the depressed patients
(n=11), 100% presented moderate/intense fatigue. In pa-
tients with no depression (n=129), 58.1% showed no fa-
tigue and from patients with no fatigue (n=78), 96.2%
showed no depression (Table 3). These data are unpublished
in literature and confirm two distinct phenomena.
Various studies on prostate, breast cancer, hematologic
tumors and other solid tumor patients have observed that
fatigue damaged their daily life activities, sexuality, quality
of life, and that it was positively related to anxiety, depres-
sive symptoms and sleep disorders(2,18).  Depression has re-
sulted in the worsening of physical performance, higher
somatic complaints, higher anxiety and feelings of insecu-
rity in inter-personal contacts and lower levels of vitality(18).
A few limitations in this present study are mentioned.
The sample was non-probabilistic avoiding generalizations
and contemplating only clinics treatment patients, exclud-
ing colorectal cancer patients admitted to the hospital. The
fact may have disguised some differences. These limitations
should be overcome in new studies.
The present research contributes for the increase and
understanding over the association of fatigue and depres-
sion comorbidities in colorectal cancer patients, and also
for the understanding of concepts differences between the
two phenomena.
CONCLUSION
Fatigue, although frequent is not well understood, lim-
iting the appropriate care for patients.  High prevalence of
fatigue was observed (49.4%), low prevalence of depres-
sion (7.1%) and moderate positive correlation between fa-
tigue and depression (r=0.395. p<0.001). Comorbidities
between fatigue and depression, under different magni-
tudes, vary between 4.5% and 12.3%.  Findings suggest fa-
tigue as more important for the existence of depression
than depression as a composer of fatigue. They are, there-
fore, two distinct phenomena.
In this context, nurses’ actions should minimize symp-
toms and occurring damages. They regard establishing strat-
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egies to identify and control fatigue and depression that
are still part of our environment, such as physical activi-
ties, alternate sleep and rest, educational programs and
cognitive behavioral actions.
 This study is pioneer in our sector and fatigue and de-
pression comorbidities in colorectal cancer patients are an
internationally innovative result.
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